BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30465048)

  • 1. Increased Fluoroquinolone-Susceptibility and Preserved Nitrofurantoin-Susceptibility among
    Datta R; Advani S; Rink A; Bianco L; Van Ness PH; Quagliarello V; Juthani-Mehta M
    Open Access J Gerontol Geriatr Med; 2018 Apr; 4(3):. PubMed ID: 30465048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Tract Infections in Long-term Care: Evaluation of Uropathogens, Antibiotic Susceptibility, and Empiric Treatment.
    Bao W; Koro M; Loh GW; Ortiz A
    Sr Care Pharm; 2022 Jun; 37(6):232-243. PubMed ID: 35610764
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of Susceptibility Patterns in Uropathogens and Empiric Antibiotic Therapy in the Emergency Department.
    Koro M; Borgert S; Abbott A; Venugopalan V
    Hosp Pharm; 2021 Dec; 56(6):745-750. PubMed ID: 34732933
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-minimization analysis of treatment options for postmenopausal women with dysuria.
    Bradley MS; Beigi RH; Shepherd JP
    Am J Obstet Gynecol; 2019 Nov; 221(5):505.e1-505.e7. PubMed ID: 31055032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating Empiric Therapy for Acute Uncomplicated Cystitis in the Outpatient Setting: A Retrospective Cohort Study.
    Natali KM; Nerenberg SF
    J Emerg Nurs; 2021 Sep; 47(5):789-797. PubMed ID: 33926725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients.
    Sanchez GV; Baird AM; Karlowsky JA; Master RN; Bordon JM
    J Antimicrob Chemother; 2014 Dec; 69(12):3259-62. PubMed ID: 25063776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
    Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escherichia coli antimicrobial susceptibility profile and cumulative antibiogram to guide empirical treatment of uncomplicated urinary tract infections in women in the province of Québec, 2010-15.
    Delisle G; Quach C; Domingo MC; Boudreault AA; Gourdeau M; Bernatchez H; Lavallée C
    J Antimicrob Chemother; 2016 Dec; 71(12):3562-3567. PubMed ID: 27494927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of long-term care facility residence on the antibiotic resistance of urinary tract Escherichia coli and Klebsiella.
    Rosello A; Hayward AC; Hopkins S; Horner C; Ironmonger D; Hawkey PM; Deeny SR
    J Antimicrob Chemother; 2017 Apr; 72(4):1184-1192. PubMed ID: 28077671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mecillinam activity compared to ampicillin, trimethoprim/sulfamethoxazole, ciprofloxacin and nitrofurantoin against urinary tract isolates of gram-negative bacilli.
    Zhanel GG; Karlowsky JA; Schwartz B; Jensen SB; Hoban DJ
    Chemotherapy; 1998; 44(6):391-6. PubMed ID: 9755298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
    Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
    J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
    Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrofurantoin: the return of an old friend in the wake of growing resistance.
    Kashanian J; Hakimian P; Blute M; Wong J; Khanna H; Wise G; Shabsigh R
    BJU Int; 2008 Dec; 102(11):1634-7. PubMed ID: 18657135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women.
    Gupta K; Scholes D; Stamm WE
    JAMA; 1999 Feb; 281(8):736-8. PubMed ID: 10052444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in antimicrobial susceptibility of Escherichia coli urinary tract isolates at a single institution over a period of 10 years.
    Walkty A; Lagacé-Wiens PR; Karlowsky JA; Hoban DJ; Manickam K; Adam H; Pieroni P; Alfa M
    Can J Microbiol; 2012 Mar; 58(3):345-9. PubMed ID: 22369590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of urinary Escherichia coli isolates to first- and second-line empirically prescribed oral antimicrobials: CANWARD surveillance study results for Canadian outpatients, 2007-2016.
    Karlowsky JA; Lagacé-Wiens PRS; Adam HJ; Baxter MR; Laing NM; Walkty AJ; Zhanel GG
    Int J Antimicrob Agents; 2019 Jul; 54(1):62-68. PubMed ID: 31034938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time trend of prevalence and susceptibility to nitrofurantoin of urinary MDR Escherichia coli from outpatients.
    Bruyndonckx R; Latour K; Atud GA; Dubovy P; Jaspers S; Hens N; Catry B; Goossens H; Coenen S
    J Antimicrob Chemother; 2019 Nov; 74(11):3264-3267. PubMed ID: 31377782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial Resistance of Escherichia coli Causing Uncomplicated Urinary Tract Infections: A European Update for 2014 and Comparison with 2000 and 2008.
    Kahlmeter G; Åhman J; Matuschek E
    Infect Dis Ther; 2015 Dec; 4(4):417-23. PubMed ID: 26507395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.